New drug MK-4884 enters first human tests for tough cancers
NCT ID NCT07600749
First seen May 22, 2026 · Last updated May 22, 2026
Summary
This early-stage study tests a new drug called MK-4884 in people with advanced or spreading solid tumors (like colorectal, kidney, lung, or bile duct cancer). The main goal is to check the drug's safety and find the right dose. About 120 participants will receive the drug, and researchers will monitor side effects and how the drug moves through the body.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT NEOPLASM are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.